CASE STUDY
Denials Resolution & Prevention
Over $1.2 Million Recovered in Overturned Chemotherapy Drug Claims
At a Glance
Challenges
-
Unexpected denials of high-cost chemotherapy drugs due to a surprise payer policy
-
Inconsistent denials justifications and outcomes for recurring patients
-
Potential disruption to patient care and hospital operations due to drug inavailability
Solutions
- Leveraged Aspirion’s specialized legal and technical expertise
- Analysis and research of new policy to identify weaknesses in payer’s arguments
- Implemented strategic tracking system to monitor claim status and identify trends
- Applied customized appeal strategy to address the payer policy impact on patient care, hospital operations, and contractual obligations
Results
- 70% success rate in overturning denials, far exceeding initial expectations
-
Over $1.2 million recovered in disputed claims due to legal expertise
-
Increased understanding of the payer’s unusual specialty pharmacy policy to avoid future denials
About the Hospital
As a prominent, university-based medical center in the Southeast, the healthcare system provides expertise in more than 100 medical specialties and offers close to 40 outpatient sites. With 1,800 providers and scientists, it is also home to nationally ranked eye, cancer, & cardiac centers.
“Aspirion has been very responsive and flexible. The team of people who we worked with during the implementation was outstanding. We have access to people who can make decisions, and we have regular check-in calls with operational stakeholders. We like the firm to be able to show the key statistics, talk through them, and let us know whether they see an opportunity. That is the approach that Aspirion has shown so far. They collaborate, listen, and are adaptable. They have good people skills and communication, and they are a good partner. Aspirion doesn’t just sell us something for the sake of selling something and charge us for every little thing. They spend time listening to and understanding us. They are transparent about what they cannot do. The partnership has been our highlight with Aspirion.“
-Analyst/Coordinator, Aspirion Denials Management Client
Contact Us
Aspirion is proud to have been named 2024 Best in KLAS for Denials Management Services.
Contact us to find out how our high-skilled team will meet your complex revenue cycle management challenges head-on.